Physician profile
Fernando Mendoza
NPI 1063637320
$130,289.38
in general payments reported to CMS, 2019-2025
58 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,004 · 2020: $11K · 2021: $4,941 · 2022: $24K · 2023: $47K · 2024: $19K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $71K · Food and Beverage: $9,685 · Travel and Lodging: $5,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $70,811.00 |
| Food and Beverage | $9,685.32 |
| Travel and Lodging | $5,628.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $113,511.18 | 2019-2025 | |
| Abbott Laboratories | $2,207.21 | 2019-2025 | Mitraclip, Aveir, Portico |
| Novartis Pharmaceuticals Corporation | $2,071.43 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,189.66 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $1,121.25 | 2021-2025 | Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $878.94 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $861.28 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $781.12 | 2019-2025 | Verquvo, Winrevair, Capvaxive |
| Alnylam Pharmaceuticals INC. | $671.52 | 2019-2025 | Amvuttra |
| Amgen INC. | $664.65 | 2019-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $655.04 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $650.82 | 2019-2025 | Farxiga, Wainua, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $526.67 | 2019-2024 | Camzyos, Eliquis |
| Regeneron Healthcare Solutions, INC. | $357.62 | 2019-2022 | |
| Esperion Therapeutics, INC. | $315.83 | 2020-2023 | Nexletol |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $285.80 | 2019-2025 | Watchman Flx, Sentinel |
| Actelion Pharmaceuticals US, INC. | $267.70 | 2019-2025 | Opsumit, Uptravi |
| Medicure Pharma INC. | $243.23 | 2020-2022 | |
| Atricure, INC. | $215.61 | 2021-2025 | Atriclip Laa Exclusion System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $204.91 | 2019-2025 | Lifevest |
| Lilly USA, LLC | $193.36 | 2023-2025 | Mounjaro, Zepbound |
| Lexicon Pharmaceuticals, INC. | $193.12 | 2023-2024 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $183.21 | 2019-2021 | |
| Abiomed | $141.99 | 2025 | |
| Irhythm Technologies, INC. | $141.86 | 2019-2022 | |
| Bridgebio Pharma, INC. | $135.01 | 2025 | Attruby |
| Scpharmaceuticals INC. | $127.11 | 2023-2025 | |
| Bardy Diagnostics, INC. | $117.84 | 2020-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $112.08 | 2022-2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $109.28 | 2022-2025 | Assure Wcd |
| Philips North America LLC | $109.23 | 2020-2022 | |
| Glaxosmithkline, LLC. | $105.90 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Kiniksa Pharmaceuticals International, Plc | $105.18 | 2024 | Arcalyst |
| Gilead Sciences, INC. | $75.17 | 2019 | |
| United Therapeutics Corporation | $71.33 | 2019-2021 | |
| Akcea Therapeutics, INC. | $70.65 | 2020-2021 | |
| Lundbeck LLC | $68.31 | 2019-2021 | |
| Amarin Pharma, INC. | $64.80 | 2019-2022 | |
| Lantheus Medical Imaging, INC. | $44.08 | 2023-2024 | Definity |
| Heartflow, INC. | $40.47 | 2025 | |
| Recor Medical INC | $39.25 | 2025 | Paradise Ultrasound Renal Denervation System |
| Infobionic, INC | $33.40 | 2024 | Mome Device |
| W. L. Gore & Associates, INC. | $31.35 | 2020-2021 | |
| Biotronik INC. | $29.67 | 2021-2022 | |
| Vivaquant INC, Dba Rhythm Express | $28.75 | 2024 | Rhythm Express |
| Altathera Pharmaceuticals LLC | $26.44 | 2025 | Sotalol Hydrochloride |
| Sobi, INC | $25.06 | 2021 | |
| Edwards Lifesciences Corporation | $23.70 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Ortho-Clinical Diagnostics, INC. | $22.88 | 2021 | |
| Eisai INC. | $22.76 | 2021 | |
| Vifor Pharma, INC. | $20.46 | 2019 | |
| Cmp Pharma, INC. | $18.80 | 2021 | |
| Celgene Corporation | $17.66 | 2024 | Camzyos |
| Genzyme Corporation | $16.55 | 2019 | |
| Lemaitre Vascular, INC. | $14.84 | 2019 | |
| Medtronic, INC. | $14.48 | 2022 | |
| Medtronic Vascular, INC. | $11.88 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Mendoza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.